NTIC.NASDAQNorthern Technologies International CORP
DEF: NTIC Proxy Statement Details 2025 Performance, 2026 Annual Meeting
Sentiment:
Proxy Statement
Northern Technologies International Corporation (NTIC) filed its definitive proxy statement for the 2026 Annual Meeting, detailing fiscal 2025 financial results, executive compensation, and corporate governance proposals.
Worse than expectedNet income attributable to NTIC decreased significantly to $18,000 ($0.00 per diluted common share) for fiscal 2025, compared to $5.4 million ($0.55 per diluted common share) for fiscal 2024.Net sales experienced a slight decrease from the prior fiscal year's record.Quarterly cash dividends were reduced from $0.07 per share to $0.01 per share for the third and fourth quarters of fiscal 2025.ZERUST Oil & Gas net sales and Natur-Tec net sales were down from record sales in fiscal 2024.
Summary
- The Annual Meeting of Stockholders will be held on January 16, 2026, to elect eight directors, approve executive compensation on an advisory basis, determine the frequency of future say-on-pay votes, and ratify Baker Tilly US, LLP as the independent registered public accounting firm for fiscal year ending August 31, 2026.
- Net sales for fiscal 2025 were $84.2 million, a slight decrease from the previous fiscal year's record sales.
- Net income attributable to NTIC significantly decreased to $18,000, or $0.00 per diluted common share, for fiscal 2025, compared to $5.4 million, or $0.55 per diluted common share, for fiscal 2024.
- This decline in net income was primarily due to increased operating expenses, decreased gross margin, reduced income from joint venture operations, and an 'other expense' related to a Chinese Customs issue, partially offset by a one-time employee retention credit payment.
- Quarterly cash dividends were reduced from $0.07 per share to $0.01 per share for the third and fourth quarters of fiscal 2025 to conserve cash resources.
- ZERUST industrial sales increased by 2.4% in fiscal 2025 due to increased demand for North American products, while ZERUST Oil & Gas net sales and Natur-Tec bioplastics net sales were down from record sales in fiscal 2024.
- The Board of Directors unanimously recommends voting FOR all eight director nominees, FOR the advisory vote on executive compensation, FOR an annual frequency for future say-on-pay votes, and FOR the ratification of Baker Tilly US, LLP.
Sentiment
Score: 3
Explanation: The significant decline in net income and the reduction in quarterly dividends for fiscal 2025, coupled with decreases in sales for key segments like ZERUST Oil & Gas and Natur-Tec, indicate a challenging financial period. While there are positives in corporate governance and a slight increase in ZERUST industrial sales, the overall financial performance is concerning.
Positives
- ZERUST industrial sales increased by 2.4% in fiscal 2025 due to increased demand for North American products.
- The company maintains 15 active joint ventures providing access to global markets with an estimated annual global market potential of $500 million.
- Operates in over 65 countries worldwide through its network of joint ventures and 12 wholly or majority-owned operating subsidiaries.
- Strong corporate governance practices are in place, including annual election of directors, 75% independent directors, an independent Board Chair, and a robust clawback policy.
- The company is committed to ESG principles, utilizing electricity generated by 100% renewable sources for all US facilities (offsetting 380 metric tons of carbon dioxide annually) and developing green manufacturing processes.
- Workforce diversity includes 42% female employees and 29% racially or ethnically diverse employees, with management comprising 40% female leaders and 23% racially or ethnically diverse leaders.
Negatives
- Net sales of $84.2 million in fiscal 2025 represent a slight decrease from the prior fiscal year's record sales.
- Net income attributable to NTIC decreased significantly to $18,000 ($0.00 per diluted common share) for fiscal 2025, compared to $5.4 million ($0.55 per diluted common share) for fiscal 2024.
- The decrease in net income was primarily due to increases in operating expenses, decreases in gross margin, reduced income from joint venture operations, and an 'other expense' incurred as a result of a Chinese Customs issue.
- Quarterly cash dividends were reduced from $0.07 per share to $0.01 per share for the third and fourth quarters of fiscal 2025 to conserve cash resources.
- ZERUST Oil & Gas net sales were down from record sales in fiscal 2024.
- Natur-Tec net sales were down from record sales in fiscal 2024.
Risks
- A challenging macroenvironment is impacting financial performance.
- Increases in operating expenses are contributing to reduced profitability.
- Decreases in gross margin are negatively affecting financial results.
- Decreased income from joint venture operations poses a challenge.
- An 'other expense' was incurred as a result of a Chinese Customs issue.
- Potential for executives to leave in the event of a change in control, necessitating retention incentives.
- Risk of financial restatements or incorrect calculation of financial metrics impacting incentive compensation.
- Risk of executives engaging in egregious conduct detrimental to NTIC.
- The Board oversees operational, financial (accounting, credit, liquidity, tax), legal, compensation, competitive, cybersecurity, health, safety, environmental, economic, political, and reputational risks.
Future Outlook
The company expects to conduct an annual say-on-pay vote at its 2027 Annual Meeting of Stockholders and the next frequency of say-on-pay vote at its 2032 Annual Meeting of Stockholders. Management typically formulates three-year financial targets, and the Board approves an annual business plan at the beginning of each fiscal year.
Management Comments
- Our guiding compensation philosophy is to maintain an executive compensation program that allows us to attract, retain, motivate and reward qualified and talented executives who will enable us to grow our business, achieve our annual, long-term and strategic goals and drive long-term stockholder value.
- We are committed to creating a more sustainable future. We convert unique, environmentally beneficial materials science into value-added products and services for industrial and consumer applications.
- Our research and development teams deliver innovative technologies and products that address climate change, use renewable materials, and enable sustainable waste management.
- We believe that sustainability means being a responsible and ethical corporate citizen, and we support employees as they give back to the communities in which they live and work by engaging in efforts to strengthen community relationships and foster employee engagement.
Industry Context
The company operates in industrial manufacturing (rust and corrosion inhibiting solutions), oil and gas (corrosion mitigation), and bioplastics (biobased and compostable plastics). While ZERUST industrial sales saw a modest increase, ZERUST Oil & Gas and Natur-Tec bioplastics experienced declines from prior record sales, suggesting a mixed performance across its diverse segments, potentially influenced by the 'challenging macroenvironment' mentioned in the filing. The bioplastics segment's focus on reducing carbon footprint and sustainable waste management aligns with growing global environmental concerns and demand for green alternatives.
Comparison to Industry Standards
- The filing states that there are no public companies substantially similar to NTIC in terms of its business, industry, and corporate profile, thus direct comparisons to specific comparable companies, projects, or results are not provided within the document.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Compensation Committee Chair | Konstantin von Falkenhausen | Sarah E. Kemp | November 2024 | Board committee refreshment efforts. |
| Nominating and Corporate Governance Committee Chair | Sarah E. Kemp | Konstantin von Falkenhausen | November 2024 | Board committee refreshment efforts. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Committee Chair Rotation | Chairs of the Compensation Committee and Nominating and Corporate Governance Committee were rotated to refresh Board committees. | November 2024 | Aims to enhance committee effectiveness and bring fresh perspectives to oversight responsibilities. |
| Voting Standard Change | Adopted a plurality plus vote standard for uncontested director elections, with a director resignation policy, replacing a simple plurality vote standard. | NA | Increases stockholder influence over director elections and promotes greater accountability for director performance. |
| Long-Term Incentive Vesting | Extended the vesting of annual stock option grants to a three-year period. | NA | Aligns long-term incentives more closely with stockholder interests and enhances executive retention. |
| ESG Policy Adoption | Adopted a Health, Safety and Environment Policy and Human Rights Policy. | NA | Formalizes the company's approach to ESG matters and increases visibility of ESG efforts. |
| Clawback Policy Adoption | Adopted a robust, Nasdaq-compliant clawback policy applicable to financial restatements, incorrect financial metric calculations, or egregious executive conduct. | NA | Ensures recovery of incentive compensation under specified adverse conditions, strengthening accountability and corporate integrity. |
| Stock Ownership Guidelines | Adopted stock ownership guidelines for executive officers and directors. | November 2021 | Aligns the interests of executive officers and directors with those of stockholders. |
Legal Proceedings
- The CEO's individual performance objectives for fiscal 2025 included 'management of pending litigation,' indicating ongoing legal matters, but no specific details of legal proceedings are disclosed in the filing.
Related Party Transactions
- A consulting agreement exists with Bioplastic Polymers LLC, an entity owned by director Ramani Narayan, Ph.D., for which the company paid $144,000 in fiscal 2025 for services related to the Natur-Tec business and bioplastics program.
- G. Patrick Lynch, President and CEO, is a stockholder of Inter Alia Holding Company, which owns 12.7% of NTIC's total voting power. He shares voting and dispositive power over these shares with three other family members.
- Indemnification agreements are in place with all directors and executive officers, requiring the company to indemnify them against certain expenses and liabilities incurred in connection with their service.
Stakeholder Impact
- Shareholders: Experienced a significant decrease in net income and a reduction in quarterly dividends, negatively impacting returns. Corporate governance enhancements aim to align long-term interests.
- Employees: Received a one-time employee retention credit payment, 4.0% base salary increases for executives, and 401(k) matching contributions. The company is committed to health, safety, equity, and inclusion.
- Customers: Benefit from ZERUST solutions for corrosion problems, reduced operating costs, and increased productivity. Natur-Tec bioplastics offer environmentally sound waste disposal options and carbon footprint reduction.
- Suppliers: Expected to comply with the company's Vendor Code of Conduct, ensuring lawful, ethical, and integrity-driven operations.
- Creditors: The reduction in quarterly dividends to conserve cash resources could be viewed positively by creditors as it strengthens the company's liquidity position.
Next Steps
- Elect eight directors at the Annual Meeting on January 16, 2026.
- Approve, on an advisory basis, the compensation of named executive officers.
- Indicate, on an advisory basis, the frequency of future votes to approve executive compensation (Board recommends one year).
- Ratify the appointment of Baker Tilly US, LLP as independent registered public accounting firm for fiscal year ending August 31, 2026.
- Conduct a say-on-pay vote at the 2027 Annual Meeting of Stockholders.
- Conduct the next frequency of say-on-pay vote at the 2032 Annual Meeting of Stockholders.
- Stockholders can submit proposals for the 2027 Annual Meeting by August 3, 2026 (Rule 14a-8) or between September 18, 2026, and October 18, 2026 (Bylaws).
Key Dates
| Date | Description |
|---|---|
| 2004-01-01 | Sunggyu Lee, Ph.D. began serving as a director of NTIC. |
| 2004-02-01 | G. Patrick Lynch began serving as a director of NTIC. |
| 2004-09-01 | Baker Tilly US, LLP began serving as independent registered public accounting firm. |
| 2004-11-01 | Ramani Narayan, Ph.D. began serving as a director of NTIC. |
| 2005-07-01 | G. Patrick Lynch became President of NTIC. |
| 2006-01-01 | G. Patrick Lynch became Chief Executive Officer of NTIC. |
| 2010-02-01 | Richard J. Nigon began serving as a director of NTIC. |
| 2012-11-01 | Richard J. Nigon became non-executive Chairman of the Board. |
| 2012-11-01 | Konstantin von Falkenhausen began serving as a director of NTIC. |
| 2015-04-01 | Cristina Pinho became Chair of the Board of Instituto Lusa Pinho Sartori. |
| 2017-02-01 | Sarah E. Kemp became Deputy Under Secretary for the International Trade Administration at the U.S. Department of Commerce. |
| 2019-09-01 | Nancy E. Calderon retired from KPMG LLP. |
| 2019-10-01 | Nancy E. Calderon began serving as a director of NTIC. |
| 2019-10-01 | Sarah E. Kemp began serving as a director of NTIC. |
| 2020-01-01 | Last frequency of say-on-pay vote held at Annual Meeting of Stockholders. |
| 2021-11-01 | Stock ownership guidelines for directors and executive officers established. |
| 2022-02-01 | Sarah E. Kemp became Vice President, International Government Affairs at Intel Corporation. |
| 2023-01-01 | Cristina Pinho began serving as a director of NTIC. |
| 2024-09-01 | Stock option grants to executives (Mr. Lynch 44,858 shares, Mr. Wolsfeld 33,156 shares) and non-employee directors (restricted stock units or stock options). |
| 2024-11-01 | Compensation Committee and Nominating and Corporate Governance Committee Chairs rotated. |
| 2025-01-17 | 2025 Annual Meeting of Stockholders held, with approximately 93% approval for say-on-pay. |
| 2025-08-29 | Last trading day of fiscal 2025, common stock closing price $7.40. |
| 2025-08-31 | Fiscal year ended. |
| 2025-09-01 | Stock option grants to executives (Mr. Lynch 44,051 shares, Mr. Wolsfeld 32,559 shares). |
| 2025-11-13 | Schedule 13G/A filed by Needham Investment Management L.L.C. |
| 2025-11-14 | Audit Committee Report dated. |
| 2025-11-18 | Record date for 2026 Annual Meeting of Stockholders. |
| 2025-12-01 | Expected mailing date of Notice of Internet Availability of Proxy Materials; Proxy materials posted online; Date of Notice of Annual Meeting of Stockholders. |
| 2026-01-06 | Stockholder list available at corporate offices for examination. |
| 2026-01-16 | 2026 Annual Meeting of Stockholders at 8:00 a.m. Central Standard Time. |
| 2026-08-03 | Deadline for stockholder proposals for 2027 Annual Meeting under Rule 14a-8. |
| 2026-08-31 | Fiscal year ending for which Baker Tilly US, LLP is appointed independent registered public accounting firm. |
| 2026-09-18 | Earliest date for stockholder nominations/proposals for 2027 Annual Meeting under Bylaws. |
| 2026-10-18 | Latest date for stockholder nominations/proposals for 2027 Annual Meeting under Bylaws. |
| 2027-01-11 | Consulting agreement with Bioplastic Polymers LLC (Ramani Narayan, Ph.D.) terminates. |
| 2027-01-15 | Anticipated date for 2027 Annual Meeting of Stockholders. |
| 2032-01-01 | Next required advisory vote on the frequency of future stockholder advisory votes on executive compensation. |
Recommendation
sellThe substantial decline in net income to near break-even levels and the significant reduction in quarterly dividends from $0.07 to $0.01 per share for fiscal 2025 are strong indicators of deteriorating financial performance. While some segments like ZERUST industrial sales saw growth, the overall financial health, including decreases in gross margin and joint venture income, suggests underlying operational challenges. The 'challenging macroenvironment' and a 'Chinese Customs issue' are noted as contributing factors, but the magnitude of the earnings decline warrants a cautious stance. Investors should consider selling to mitigate further potential downside risk given the current financial trajectory.
Keywords
Northern Technologies International Corporation, NTIC, Proxy Statement, Annual Meeting, Executive Compensation, Corporate Governance, Fiscal 2025 Results, Net Sales, Net Income, Dividends, ZERUST, Natur-Tec, Bioplastics, Corrosion Management, ESG, Stock Options, Board of Directors, Audit Committee, Compensation Committee, Nasdaq
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.